Energy (NYSEARCA: XLE) tops the S&P 500's 11 stock sectors in the early days of 2025, shaking off two straight years when it ...

Theratechnologies (THTX) said there will be a shortage of its drug Egrifta SV on the patient level in mid-January due to a ...

We believe broadening tariffs to progressively more products will hit U.S. consumers harder and could induce a significant ...

GitLab is a promising investment opportunity, with strong revenue growth, competitive positioning, and potential for profit ...

Read why Warren Buffett has been buying Occidental Petroleum (OXY) shares and why you should consider investing in the ...

Host Hotels' Q3'24 results were strong, with revenue growth and strategic share buybacks, despite challenges. See why HST ...

Aalberts is navigating challenges in building and industrial sectors, focusing on the US market for growth, potential for ...

We warn of potential overvaluation and high capital expenditure needs for data center REIT Equinix, recommending a Sell ...

ZECP owns consistent earners, not fast-growing stocks, without offering a compelling valuation discount. See why the Fund is ...

We see potential for Qualcomm in 2025 with Samsung partnership, but Apple's 5G modems could impact revenue. Read more on QCOM ...

C3.ai's strategic alliance with Microsoft Azure is transforming Enterprise AI, driving growth and promising future outlook.

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...